Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

GC Therapeutics

Request full access

Synthetic biology solutions programming patient-derived stem cells into any cell type with unmatched efficiency, speed, and scalability

Cambridge, United StatesFounded 2019Biotech & Life Sciences

About GC Therapeutics

GC Therapeutics Inc. (GCTx) leverages synthetic biology to reprogram patient-derived stem cells into any desired cell type with unparalleled efficiency, speed, and scalability. This innovative approach allows the company to dictate cell fates in a single step, making it a game-changer in the fields of cell therapies, transplants, and disease-specific cell tailoring. GCTx serves a diverse clientele, including medical researchers, pharmaceutical companies, and healthcare providers, operating primarily in the biotechnology and healthcare markets. The company’s business model revolves around providing customized cell programming solutions and validated cell types for various medical applications. Revenue is generated through service contracts, partnerships, and licensing agreements.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2019
Headquarters
Cambridge, United States
Employees
45
Open positions
1
Dealroom signal
78.5/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCOther financing Oct 2024 $0 — Global Brain Corporation ↗
SERIES AOther financing Sep 2024 $65M $260M Cercano Management · Pear Ventures · Andreessen Horowitz · Mubadala Capital ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

GC Therapeutics website traffic

Latest recorded traffic for GC Therapeutics is 4.2K monthly website visits, up 5% over the last three months. GC Therapeutics's team grew 9.8% over the past year.

Latest monthly visits4.2K 3-month web change+5% 1-year team growth+9.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

GC Therapeutics in the Cambridge ecosystem

Live from Dealroom

The GC Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A6 investors entered at this stage

Other known investors1 additional known investor

  • Harvard University
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States97.7%
🇦🇹 Austria2.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about GC Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GC Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.